Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Colon Cancer Prevention Study
Trial Name: Name of Trial: Statin Polyp Prevention Trial in Patients with Resected Colon Cancer Protocol ID Number: NSABP P-5
Protocol ID: NSABP P-5
Previous malignancies unless the patient has been disease-free for 5 or more years prior to study entry and is deemed by the physician to be at low risk for recurrence. Patients with the following cancers are eligible if diagnosed and treated within the past 5 years: all in situ cancers and basal cell and squamous cell carcinoma of the skin.
Enrollment: • About 1740 men and women from different cancer centers will take part in this study.
Taking part in this study may or may not make your health better. While doctors hope that rosuvastatin will be useful in cancer prevention, there is no proof of this yet. A possible benefit may be the prevention of colon or rectal polyps that could lead to cancer. We hope the information learned from this study will help patients in the future who are at increased risk for developing polyps of the colon and rectum.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Jul 5, 2012
Updated: Jan 18, 2013